Navigation Links
BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010
Date:9/14/2010

Treatment" will be presented by Joanne Liutkus, M.D., Medicine Professional Corporation, Cambridge, Ontario, Canada


  • Poster: Presentation #836, Sept. 21, 1:30-2:30 p.m. CEST

    • "Meta-Analysis of the Efficacy of GLP-1R Agonists and DPP-4 Inhibitors for Treatment of Type 2 Diabetes Mellitus" will be presented by Vanita Aroda, M.D., MedStar Research, Hyattsville, Md.


  • Poster: Presentation #837, Sept. 21, 1:30-2:30 p.m. CEST

    • "Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated with Exenatide or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLink™ Database" will be presented by Jennie Best, Ph.D., Amylin


  • Poster: Presentation #842, Sept. 22, 12:30-1:30 p.m. CEST

    • "DURATION-2: Effect of Switching to Once-Weekly Exenatide from Maximum Daily Doses of Sitagliptin or Pioglitazone" will be presented by Carol H. Wysham, M.D., Rockwood Clinic, Spokane, Wash.


  • Poster: Presentation #858, Sept. 23, 12:30-1:30 p.m. CEST

    • "Antibodies to Exenatide did not Cross-React with Human GLP-1 or Glucagon or Alter the Efficacy or Safety of Exenatide" will be presented by Mark Fineman, Amylin


  • Poster: Presentation #863, Sept. 23, 1:30-2:30 p.m. CEST

    • "Impact of Exenatide Once Weekly and Insulin Glargine on Glucose Control and Cardiovascular Risk Factors in Subjects with Type 2 Diabetes" will be presented by Michaela Diamant, M.D., Diabetes Centre, VU University Medical Centre, AmsterdamBYDUREON (pronounced by-DUR-ee-on) is the proposed brand name for exenatide once weekly. It is an investigational, extended-release medication for type 2 diabetes designed to deliver continuous therapeutic levels of exenatide in a single weekly dose. BYDUREON is a once-weekly formulation of exenatide, the active ingredient in BYETT
    '/>"/>

    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. DynaMatrix™ to be Featured on Discovery Channel Segment Highlighting Innovative Products in Oral Health
    2. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
    3. CardioGenics Featured on Canadas Business News Network
    4. Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter
    5. Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology
    6. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
    7. LightLabs C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America
    8. Research Evaluating Effectiveness of Behavioral Counseling and Varenicline for Smoking Cessation Featured in the American Journal of Preventive Medicine
    9. 4-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499
    10. Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News
    11. Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowleys American Scene Radio Program and Featured on Money Channel Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... , May 17, 2013  Sanofi (EURONEXT: SAN and ... pivotal study, JAKARTA , examining the ... primary endpoint in both dose groups. The primary endpoint ... spleen volume. Consistent with data reported in previous trials, ... and vomiting. Full results will be presented at an ...
    (Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... announced that it will release its unaudited financial results for ... Tuesday, May 28, 2013.  The Company will host a conference ... (May 28, 2013 at 8:00 p.m. China Standard Time) to ... recent corporate developments. To access the conference call, ...
    (Date:5/16/2013)... and ZURICH , May 17, ... Agency for Science, Technology and Research (A*STAR) and ... first healthy volunteer has been dosed in a Phase 1 ... Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this ... this novel vaccine candidate and its potential to protect against ...
    Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
    ... 2007 -- CytImmune, a,clinical stage nanomedicine company ... therapies has,been selected to present a poster abstract ... Meeting in Chicago Illinois,June 1-5. The poster session ... on June 3. Dr. Lawrence Tamarkin, CEO of ...
    ... in Journal of Cell Science Shows ONCONASE Uptake ... 05, 2007 /PRNewswire-FirstCall/ --,Alfacell Corporation today announced that ... follows to enter,cells. , Published in the Journal ... on studies conducted at the University of Girona ...
    Cached Medicine Technology:CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3
    (Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
    (Date:5/20/2013)... The Semi Truck Accident Victims Center ... service for an innocent victim of a catastrophic semi ... our services are unparalleled. What this means is if ... of a passenger vehicle involved in a semi truck ... Ohio, New Jersey, Indiana, Maryland, Georgia, Nebraska, Kansas, Michigan, ...
    (Date:5/20/2013)... Toronto, ON (PRWEB) May 20, 2013 ... hosted VoIP, Video, Data and IT Security solution ... video series aimed at providing business customers ... return of investments in BroadConnect services. With the ... product managers offer valuable insight into some of ...
    (Date:5/20/2013)... 20, 2013 On May 14th, premiere ... testimonial about how one of its patients originally came ... after being diagnosed with giant papillary conjunctivitis. “Giant papillary ... the eye, and for one of our patients in ... allergy,” says the Medical Director of the Atlanta Vision ...
    (Date:5/20/2013)... AlignLife of Waunakee is proud to announce ... the Tri-4-Schools children’s triathlon. Tri-4-Schools is a nonprofit organization ... kids active and fight childhood obesity. Their events aim ... nutrition, sportsmanship and self-confidence. Tri-4-Schools hopes to instill the ... and under so they can make healthy choices that ...
    Breaking Medicine News(10 mins):Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Semi Truck Accident Victims Center Urges Family Members Of Victims Injured In A Horrific Semi Truck Accident In Any US State To Call Them First For An Unsurpassed Response 2Health News:BroadConnect’s Latest Video Solution Sets Aimed at Providing Technical Insights for Businesses Hoping to Gain Greater Returns from their Investment in Communication and Security Solutions 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2
    ... replacement care, according to Dr. Xueya Cai and colleagues ... work, published online in Springer,s journal Clinical Orthopaedics and ... likely than Caucasians to receive total knee arthroplasty (or ... is widely performed in patients of all races with ...
    ... , TUESDAY, Sept. 13 (HealthDay News) --,Two decades after the ... abnormalities in their brains that in some cases have even ... part of a debilitating disorder known as Gulf War illness. ... to be caused by exposure to neurotoxins and nerve gas. ...
    ... study finds that infections following cardiac device implantations or ... in terms of patient mortality, even months after affected ... led to 4.8 to 7.7-fold increases in admission mortality, ... 4.0-fold increases in hospital length of stay, and 1.4 ...
    ... Chicago Many patients are responding to a new, ... out the bad cells. Atrial fibrillation (A-Fib) is one ... arrhythmia affecting Americans. However, new research shows that 70 ... with cryoballoon ablation, the freezing technique, are free of ...
    ... Steele HealthDay Reporter , MONDAY, Sept. 12 ... help people with mild memory problems or early Alzheimer,s ... small study suggests. But, the study authors added, ... therapy will actually benefit patients. Alzheimer,s disease, the ...
    ... WINSTON-SALEM, N.C. September 12, 2011 A year ... listening to doctor,s orders when it comes to taking ... of Wake Forest Baptist Medical Center shows. However, there ... "Medication non-compliance is a major risk factor for stroke ...
    Cached Medicine News:Health News:Does race dictate quality of care? 2Health News:Brain Blood Flow Abnormalities Persist in Gulf War Vets 2Health News:Costs, mortality skyrocket following infection in cardiac device recipients 2Health News:Freeze and desist: Disabling cardiac cells that can cause arrhythmia 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 2Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 4
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: